Fennec Pharma Employee Directory

Fennec Pharma corporate office is located in 68 Tw Alexander Dr, Durham, North Carolina, 27713, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Sales

16

Medical & Health

3

Finance

2

Human Resources

2

Operations

2

Marketing

2

Legal

1

Fennec Pharma CEO

JH
United States flag for contact location.
Jeff HackmanChief Executive Officer & Director
PhonePhoneEmailEmail
See Profile

Key Employees of Fennec Pharma

Fennec Pharma Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Fennec Pharma

Hundreds of professionals searching for Fennec Pharma have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Fennec Pharma

Explore people who held key positions, contributed to Fennec Pharma's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in North Carolina, United States

Frequently Asked Questions Regarding Fennec Pharma Employees

How many employees does Fennec Pharma have?
Fennec Pharma has 11-50 employees
Who is the CEO of Fennec Pharma?
Fennec Pharma’s CEO is Jeff Hackman
Who are Fennec Pharma key employees?
Some of Fennec Pharma key employees are Hamad Ejaz, Christie Cioffi, Terry Evans
Where is Fennec Pharma located?
Fennec Pharma’s headquarters are located at 68 Tw Alexander Dr, Durham, North Carolina, 27713, United States
How do I contact Fennec Pharma?
Fennec Pharma Contact Info: Phone number: (919) 636-4530 Website: www.fennecpharma.com
What does Fennec Pharma do?

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina, that specializes in developing and commercializing therapies to reduce the risk of hearing loss caused by platinum-based chemotherapy, particularly in pediatric patients. Its flagship product, PEDMARK®, a formulation... of sodium thiosulfate, is designed to prevent platinum-induced ototoxicitya serious side effect of cisplatin chemotherapyin children with localized, non-metastatic solid tumors, and has received FDA approval. A related formulation, PEDMARQSI®, has been authorized for pediatric use in Europe and the U.K., and is being commercialized internationally through an exclusive licensing partnership with Norgine Pharmaceuticals Ltd.Read More

Is Fennec Pharma a public company?
Yes, Fennec Pharma is a public company and is traded under the symbol FENC
See more information about Fennec Pharma Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.